Osmotic gradients across organelle and plasma membranes modulate the rates of membrane fission and fusion; sufficiently large gradients can cause membrane rupture [1] [2] [3] [4] [5] [6] . Hypotonic gradients applied to living yeast cells trigger prompt (within seconds) swelling and fusion of Saccharomyces cerevisiae vacuoles, whereas hypertonic gradients cause vacuoles to fragment on a slower time scale [7] [8] [9] [10] [11] . Here, we analyze the influence of osmotic strength on homotypic fusion of isolated yeast vacuoles. Consistent with previously reported in vivo results, we find that decreases in osmolyte concentration increase the rate and extent of vacuole fusion in vitro, whereas increases in osmolyte concentration prevent fusion. Unexpectedly, our results reveal that osmolytes regulate fusion by inhibiting early Rab-dependent docking or predocking events, not late events. Our experiments reveal an organelle-autonomous pathway that may control organelle surface-to-volume ratio, size, and copy number: Decreasing the osmolyte concentration in the cytoplasmic compartment accelerates Rab-mediated docking and fusion. By altering the relationship between the organelle surface and its enclosed volume, fusion in turn reduces the risk of membrane rupture.
Results

Organelle-Autonomous Regulation of Fusion by Osmolyte Concentration
The yeast vacuole is, like the mammalian lysosome, the terminal compartment of the endocytic pathway. Our cell-free fusion system ( Figure S1 , available online) places purified yeast vacuoles in a standard reaction buffer containing physiological salts, 200 mM sorbitol, and ATP. Decreasing the sorbitol concentration in the buffer increased the extent ( Figure 1A ) and rate ( Figure 1B ) of fusion. Conversely, increasing the sorbitol concentration decreased the extent and rate of fusion and lengthened the lag time prior to fusion ( Figure 1B ). Quantitative morphometry ( Figure 1C ) of fusion reactions corroborated the results from content-mixing assays. These in vitro results closely mirror observations of living cells [7] [8] [9] [10] [11] . The inhibitory effect of sorbitol is due to osmotic strength rather than sorbitol's specific physical or chemical properties. Replacement of sorbitol with other small polar osmolytes, including trehalose, glycerol, and sucrose ( Figure S2A ; unpublished data), yielded results comparable to sorbitol. Glycerol and trehalose are present at up to several percent (wt/vol) in living yeast cells [12] , indicating that they are not intrinsic inhibitors of membrane traffic. Dissolved solutes alter viscosity and, through excluded-volume and hydration effects, the chemical activity of water [13, 14] . A 15% solution of dextran-5 is more viscous than a 15% solution of sorbitol but has less than one-tenth as much osmotic strength; it slightly stimulated fusion ( Figure S2A ). Thus, viscosity per se does not prevent fusion. The results obtained with dextran-5 and bovine serum albumin ( Figure S2A ) further indicate that excluded-volume effects [13, 14] cannot explain inhibition by sorbitol. Excluded-volume and hydration effects also shift the ionic optima of many enzymatic reactions. Fusion is most efficient at w125 mM KCl; this sharp ionic optimum did not shift appreciably as the sorbitol concentration was varied ( Figure S2B ). Thus, small polar solutes decrease the rate of fusion by increasing osmotic strength. This effect is organelle autonomous, requiring neither cytosol nor an intact plasma membrane.
Osmotic Control of an Early Docking or Predocking Subreaction
To map the osmotic effect to specific subreactions of fusion ( Figure S1 ), we performed kinetic studies with stage-specific inhibitors ( Figure 2A) . A master fusion reaction was initiated. At intervals, reaction aliquots were transferred to tubes containing the specified treatments, incubated further, and assayed for fusion. This approach tracks loss of susceptibility to each treatment, i.e., the kinetics of completion of each subreaction. Treatments that modulate only early subreactions exhibit kinetics shifted left of the anti-Vam3 (docking) curve. Treatments that modulate later subreactions map between the anti-Vam3 and ''ice'' (content-mixing) curves. Unexpectedly, 1.4 M sorbitol inhibited fusion at early but not late time points (Figure 2A ). After 20 min, fusion was less than 90% resistant to sorbitol addition, even though docking (anti-Vam3 curve) was less than 80% complete and content mixing (ice curve) was only w30% complete. Lowering sorbitol to 100 mM yielded identical kinetics: Fusion was accelerated at early times but not late times.
Because the osmotic effect mapped to early docking, we hypothesized that osmolytes modulate the kinetics of earlyor intermediate-stage subreactions. To test this hypothesis, we assayed subreaction kinetics at three sorbitol concentrations ( Figure 2B ). The earliest subreaction, Sec18-and Sec17-mediated priming [15, 16] , was not substantially influenced by osmotic strength. Sec17 release from the membrane, a biochemical correlate of priming, was also unaltered ( Figure 2B , inset). All subsequent stages of the reaction were accelerated by reduced sorbitol concentration (100 mM versus 200 mM sorbitol) and slowed as sorbitol was added: tethering and docking (rGdi1, an inhibitor of Rab GTPases); trans-SNARE complex formation (anti-Vam3); and content mixing (MARCKS effector-domain peptide [MED] [17] ). Thus, osmolytes regulate early docking and change the kinetics of Rabmediated subreactions. We next asked whether osmolytes regulate tethering, operationally defined by the formation of clusters of associated vacuoles [9, 18] . Consistent with the kinetic and staging data, increasing buffer osmolarity strongly decreased the efficiency of tethering ( Figure 2C ).
Osmolytes Functionally Destabilize Ypt7:GTP and the HOPS Complex
To further evaluate the molecular basis of the link between osmotic strength and fusion, we measured dosage sensitivities for several fusion inhibitors at four sorbitol concentrations ( Figure 3 and Figure S3 ). Osmolyte did not systematically change the IC 50 (50% inhibitory concentration) for affinity-purified antibodies raised against the priming factor Sec17 ( Figures  S3A and S3C ) or against the SNARE Vam3 ( Figures 3A and 3C ). Unaltered IC 50 values were also obtained for MED peptide [17] , a late-stage inhibitor of fusion that chelates acidic phospholipids ( Figure S3B ). In contrast, dose-response relationships for two Rab-specific inhibitors, the Rab-chelating chaperone rGdi1 and the GTPase activating protein (GAP) rGyp1 TBC , were closely linked to osmotic strength. IC 50 values for rGdi1 and rGyp1 TBC increased by nearly an order of magnitude as osmolyte was decreased ( Figure 3C ; compare Figure 3A to Figure 3B ). Consistent with this result, in vivo overproduction of a second Ypt7 GAP, Gyp7, caused superinhibition of vacuole fusion by osmolyte, both in intact cells and in cell-free assays (unpublished data). Thus, osmolytes inhibit Rab-regulated subreactions of fusion.
The Ypt7 effector complex HOPS is anchored to the membrane by active Ypt7:GTP, so membrane association of HOPS provides a functional proxy for Ypt7 activation [19, 20] . Differential centrifugation experiments revealed that HOPS subunits were stabilized on membranes at low osmotic strength but dissociated into the supernatant as osmotic strength was increased ( Figure 4A ). Additional experiments with the Rab chaperone rGdi and experiments with the poorly hydrolyzable GTP analog GTPgS (which stabilizes activated Ypt7) further support this interpretation (unpublished data). Taken together, the data indicate that osmolytes functionally and biochemically destabilize Ypt7:GTP and its HOPS effector complex.
Rab Hyperactivation or Bypass Partially Reverses Osmotic Effects
We asked whether treatments that increase the quantity of active Rab GTPase or attenuate the Rab requirement could restore fusion at elevated osmotic strength. First, we exploited our previous finding that the recombinant SNARE rVam7 bypasses the priming requirement for ATP [21, 22] . rVam7 also reduces the Rab requirement and stabilizes HOPS on the vacuole membrane [21] [22] [23] [24] . At elevated sorbitol concentrations, rVam7 restored fusion to approximately half the level observed under the standard condition ( Figure 4B , top). At lower sorbitol concentrations (100 mM), rVam7 slightly suppressed fusion. This effect might result from SNARE-mediated lysis [24] .
Second, we tested whether osmolyte-mediated inhibition is attenuated when there is more active Rab on the vacuole membrane. Gyp7 is the major Ypt7 GAP in vivo, and vacuoles purified from gyp7D cells have elevated levels of both Ypt7:GTP and HOPS (unpublished data). When fusion of vacuoles from gyp7D cells was measured at different concentrations of osmolyte, the effect of osmolyte was attenuated, as with rVam7 addition (Figure 4B, middle) . Moreover, addition of rVam7 to vacuoles isolated from gyp7D cells had an additive effect, resulting in fusion at elevated osmotic strength that approached the standard condition (data not shown).
Third, we exploited the finding that removal of the vacuolar casein kinase I Yck3 dramatically reduces the requirement for Ypt7:GTP both in vitro [11] and in vivo (unpublished data). Vacuoles isolated from yck3D mutant cells ( Figure 4B , bottom), like vacuoles from gyp7D mutants, fused more robustly than vacuoles from wild-type cells as the osmolyte concentration increased. Hence, the inhibitory effect of osmotic strength is attenuated by three independent manipulations that either stabilize the activated Rab or decrease the Rab requirement.
Discussion
Osmoregulation of docking and fusion is widespread, but the mechanisms of osmotic sensing and the molecular targets of this regulation are unknown. In Paramecium, membrane tension generated by osmotic pressure was hypothesized to trigger cycles of vacuole exocytosis for locomotion [2] . In mammalian cells, the rapid coalescence of intracellular organelles, triggered by hypo-osmotic gradients, was reported almost a century ago [1] . There is a general correlation between low osmolarity in the cytoplasm or high osmolarity in an extracytoplasmic compartment and fusion [3] [4] [5] [6] . For example, exocytosis is triggered by extracytoplasmic osmolytes, such as sucrose [5, 6] , and inhibited by osmolyte in the cytoplasmic compartment [3] . In this study, we found that osmotic shifts influence fusion when applied during early docking but are without effect during later subreactions. Taken together, our experiments show that osmolytes can control an organelle's docking machinery in an organelle-autonomous manner, and they are fully consistent with earlier in vivo observations [7] [8] [9] [10] [11] .
In principle, osmosensors could operate directly, e.g., by detecting changes in hydration, or indirectly, by sensing changes in membrane properties as osmotic gradients cause water and ionic species to flow across a membrane. Dai et al. recorded spontaneous lateral tension changes of w40 mN/m during exocytosis and endocytosis in rat basophilic leukemia cells [4] . Both organelle-organelle and exocytotic fusion events introduce slack into the product membrane, increasing the surface-to-volume ratio of the organelle or cell. This in turn increases the capacity for inward water movement without lysis. Thus, the ability of the docking machinery to respond to osmolytes may serve to prevent membrane tension from rising to perilous (lytic) levels during osmotic stress. Lytic tension for lysosomes and vacuoles may be lower than for other membranes because lysis might be accelerated by lipases and other hydrolases that reside within the organelle lumen. Hypoosmotic stress can rupture lysosomes, to catastrophic effect [25] , and experiments by Starai and coworkers [24] demonstrated that SNARE overabundance promotes membrane rupture, indicating that even normal membrane traffic functions are not without hazards. Coupling the activity of the docking machinery to cytoplasmic osmolyte concentration or to transmembrane osmotic gradients may be central to maintenance of organelle surface-to-volume relationships and membrane integrity. 
Experimental Procedures Yeast Strains
For fusion assays, we used complimentary strain pairs of either BJ3505 (MATa pep4::HIS3 prb1-1.6R his3-200 lys2-801 trp1101 (gal3) ura3-52 gal2 can1) and DKY6281 (MATa leu2-3 leu 2-112 ura3-52 his3-200 trp1-901 lys2-801) or BY4742 pho8D and BY4742 pep4D (MAT a ura3D leu2D his3D lys2D pep4D::neo; Invitrogen, Carlsbad, CA). BJ3505 gyp7D::URA3 and DKY6281 gyp7D::URA3 were gifts from Dr. Dieter Gallwitz (Max Planck Institute of Biophysical Chemistry, Gö ttingen, Germany). BY4742 yck3D pho8D (= AMY809) and BY4742 yck3D pep4D (= AMY807) were constructed by crossing and sporulating BY4741 yck3D (MATa his3D leu2D met15D ura3D yck3D::neo; Invitrogen) against BY4742 pep4D::neo or BY4742 pho8D::neo. Genotypes of the resulting haploid strains were confirmed by PCR and DNA sequencing.
Reagents
All biochemical reagents were purchased from Sigma-Aldrich (St. Louis, MI) or Invitrogen, except as indicated, and were of biotechnology grade or better. The endoglucanase fraction of Zymolyase 20T (Seikigaku Kogyo, Tokyo, Japan) was purified by cation-exchange chromatography before use in vacuole isolation. Purified proteins used include recombinant Vam7 (rVam7 [21] ; unpublished data); recombinant Gdi1 (rGdi1) purified from bacterial cells with a CBP-intein fusion system provided by V. Starai and W. Wickner; recombinant catalytic domain of Rab-GAP Gyp1 (rGyp1 TBC ) [19] ; synthetic MARCKS Effector Domain peptide [17] ; and recombinant protease inhibitor Pbi2. Rabbit polyclonal sera raised against Vps41, Vps33, Vps18, Vps11, Ypt7, Sec17, and Vam3 were gifts from W. Wickner (Dartmouth College, Hanover, NH), and were affinity purified and in some cases crossadsorbed against cell lysates from corresponding yeast deletion mutants to eliminate crossreactivity. The protein reagents used in fusion assays were prepared in 10 mM Pipes-KOH (pH 6.8) 200 mM sorbitol (PS) or were exchanged into this buffer by dialysis or size-exclusion chromatography.
Fusion
Vacuoles were purified as described [26] . Isolated vacuoles (6 mg) were incubated for 90 min at 27 C in standard reaction buffer: PS buffer Figure S3D . , 600, or 1000 mM sorbitol and then sedimented. Membrane association of 4 HOPS components (Vps41, Vps33, Vps18, and Vps11), a vacuole Q a -SNARE (Vam3), and the vacuole Rab GTPase (Ypt7) was assessed by western blot with one-third of the total isolated supernatent (S) and one-tenth (0.6 mg vacuole protein) of the pellet (P). Phospho-Vps41 (*) was observed exclusively in the presence of ATP, as reported [11] .
(B) Rab activation or partial Rab bypass attenuates inhibition by osmolyte. Top: Vacuoles were incubated for 90 min with ATP at increasing sorbitol concentrations in the presence and absence of recombinant Q c -SNARE rVam7, which reduces the Ypt7 requirement in fusion [21, 22] . Middle and bottom: Vacuoles were purified from yeast strains containing or lacking Gyp7 (middle), which, when absent, stabilizes membrane association of Ypt7 and components of HOPS (unpublished data) or the vacuolar casein kinase I Yck3 (bottom), which, when absent, stabilizes HOPS on the membrane [11] . Fusion data were normalized to either the mean rate of fusion under standard conditions (ATP only, 200 mM sorbitol; top) or conditions where maximum fusion values were observed (100 mM sorbitol; middle, bottom). n R 4 for each point; error bars denote means 6 95% confidence intervals.
supplemented with salts (5 mM MgCl 2 , 125 mM KCl), CoA (10 mM), and Pbi2 (with or without ATP-regenerating system [1 mM ATP, 0.1 mg/ml creatine kinase, 40 mM creatine phosphate]). Vacuoles were always added last to a premixed reaction cocktail, unless otherwise specified. Bypass fusion was initiated with recombinant Vam7 (100 nM, except as indicated). Osmotic gradients were imposed by reducing or adding sorbitol to the standard fusion reaction buffer (200 mM sorbitol). Like sorbitol, KCl concentrations were adjusted without compensatory equiosmolar changes in other buffer constituents. The solution's total osmolalities ( Figure 1A and Table  S1) were measured with a Vapro 5520 vapor-pressure osmometer (Wescor, Logan, UT). As indicated, reactions also contained rGdi1, rGyp1 TBC , Sec17 antibody, Vam3 antibody, rGyp1 TBC , MED, or GTPgS. Total volume of each fusion reaction was 30 ml. Fusion reactions were prepared with BY4742 pho8D (or DKY6128; alkaline phosphatase deficient) and pep4D (or BJ3505; protease deficient) vacuoles (3 mg each), with or without genomic deletion of YCK3 (yck3D) or GYP7 (gyp7D). Homotypic vacuole fusion was measured with a biochemical complementation assay ( [26] ; see [18] for quantitative characterization of the reporter system). Fusion (content mixing) was quantified by measuring the ALP-catalyzed evolution of p-nitrophenolate at 400 nm. Signals were then subtracted from a background control reaction either lacking ATP or incubated on ice; the signal-to-background ratio under our standard conditions routinely exceeds 25:1. Results are reported relative to signals obtained under standard fusion conditions (200 mM sorbitol with ATP), unless otherwise indicated. Under standard conditions, the mean extent of fusion was 3.5 (n = 98) fusion units as defined previously, corresponding to approximately two rounds of fusion [18, 26] . In addition, we verified that sorbitol does not alter the efficiency of ALP activation in assays with vacuole lysates (data not shown) [18] . Vacuole membrane release of Sec17, Ypt7, and HOPS components was assessed with fusion reactions containing only protease-deficient vacuoles (6 mg pep4D or BJ3505). After incubation at 27 C for 10 min, 40 min, or 70 min, fusion reactions were immediately sedimented by centrifugation at 20,000 3 g for 5 min at 4 C. Pellet and supernatent fractions were fractionated by SDS-PAGE and analyzed by immunoblotting.
Microscopy
To examine vacuole morphology in vitro, we incubated pep4D vacuoles for times indicated (30 min or 70 min) at 27 C in fusion reaction buffer containing 3.0 mM FM4-64. After incubation, reactions were placed on ice. Then 2 ml of each reaction was mixed with 0.4% agarose, mounted on a chilled glass coverslip, and immediately imaged. Vacuole diameters and contact-zone lengths were measured from micrographs subjected to high-pass and sharpening filters with Image/J v. 1.36b software (Wayne Rasband, National Institutes of Health (NIH), Wachington, DC). Vacuole-clustering analysis was performed as described [9] with minor modifications: No cytosol was added to reactions, and KCl was not reduced to 40 mM. In brief, 5 mg of pep4D vacuoles were incubated at 27 C for 30 min in reaction buffer containing MgCl 2 (1.0 mM) and FM4-64 (3.0 mM) in the absence or presence of a lower than conventional concentration of ATP-regenerating system (0.6 mM ATP). Then 2 ml of the reaction was imaged as described above. Micrographs were acquired with an Olympus IX71 light-microscope system outfitted with an EMCCD (Andor iXon), ultrabright green-and blue-light-emitting diodes (>350 mW output) synchronized with the camera by custom electronics, a PlanApoN 1.45 NA 603 objective lens, and AndorIq v. 6.0.3.62 software (Andor Bioimaging, Nottingham, UK). Micrographs were processed with Image/J v. 1.36b (J. Rasband, NIH, http://rsb.info.nih.gov/ij/) and PhotoshopCS v. 8.0 (Adobe Systems) software.
Data Analysis
Where applicable, data sets were fit to sigmoidal dose-response functions with a nonlinear least-squares algorithm. log IC 50 estimates were extracted from the sigmoidal fits with Prism v. 4.0c software (GraphPad, San Diego, CA). Statistical comparisons were performed with two-tailed Student's t tests (paired or unpaired, as appropriate); significance was assumed at the 5% level, after Dunn-Sidak compensation for repeated comparisons.
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